Versant spinout lands $80M to go 'much broader' than the old Roche partnership that birthed it

Versant spinout lands $80M to go 'much broader' than the old Roche partnership that birthed it

Source: 
Endpoints
snippet: 

About three years after splitting from Versant Ventures’ discovery group, Pipeline Therapeutics has landed an $80 million Series C round to go “much broader” than the Roche-partnered program that birthed it.